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Trans-complementationHepatitis B virus (HBV) clone 4B replicated much more efﬁciently than clone 2A of the same genotype.
Introduction of its T1753C, A1762T, G1764A, and C1766T core promoter mutations into the 2A genome greatly
enhanced genome replication and suppressed HBeAg expression. Here we show that these effects are
mediated by transcriptional up regulation of pregenomic RNA and suppression of precore RNA. Analysis of
chimeric constructs suggested that the 5′ end of the 2A core gene conferred higher level of pregenomic RNA,
but less core protein and genome replication relative to the 4B sequence. Genome maturity of secreted
virions was reduced by mutations present in the core protein of the 2A genome but enhanced by mutations
found in the 4B core protein. The 4B core protein migrated faster than that of clone 2A. The possible links
among the various phenotypes and the responsible mutations remain to be established.
© 2009 Elsevier Inc. All rights reserved.Introduction
The hepatitis B virus (HBV) has a small DNA genome of 3.2 kb,
which contains four open reading frames termed X, P, core, and
envelope (Seeger et al., 2007). The P gene overlaps partially with the X
and core genes and completely with the envelope gene. It speciﬁes
DNA polymerase (P protein), the enzyme implicated in viral genome
replication. The core gene encodes core protein, which forms capsids
shielding viral genomic RNA or DNA. In addition, it forms part of the
coding sequence for hepatitis B e antigen (HBeAg), a secreted protein
involved in modulation of host immune response. From the envelope
gene three co-terminal envelope proteins: large (L), middle (M), and
small (S) are generated through alternative translation initiation sites.Claverick Street, 4th Floor,
ong).
el Deaconess Hospital, Harvard
l Oncology, Graduate School of
ine, Boston, MA, USA.
ll rights reserved.The envelope proteins participate in virion formation. Translation of
the seven HBV proteins is made possible by the generation of ﬁve
transcripts with different 5′ ends but an identical 3′ end: the 3.5-kb
precore RNA (pc RNA) for HBeAg, the slightly shorter 3.5-kb
pregenomic RNA (pg RNA) for core and P proteins, the 2.4-kb
subgenomic RNA for L protein, the 2.1-kb subgenomic RNA with
heterogeneous 5′ ends for M and S proteins, and the 0.7-kb
subgenomic RNA for X protein. With the exception of P gene
expression from the pg RNA, the gene to be translated is located
near the 5′ end of the transcript due to the low efﬁciency with which
the downstream genes are translated. That explains why the X protein
is not expressed from the 3.5-, 2.4-, and 2.1-kb transcripts despite the
presence of X coding sequence in all these transcripts.
The P gene translation initiation site is located about 500
nucleotides downstreamof the 5′ end of the pg RNA. It sits downstream
of the core gene initiation codon but about 150 nucleotides upstreamof
the core gene termination codon. Therefore, P protein translation is
achieved by ribosomal leaky scanning of the core gene initiator and
several internal AUGs (Fouillot et al., 1993; Hwang and Su, 1998). This
low rate of P protein expression is compatiblewith the need for just one
molecule of P protein per capsid, which is assembled from 180 or 240
copies of core protein. As expected, experiments in the related duck
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protein translation reduced P protein expression,whereas ablating core
protein expression increased P protein translation (Sen et al., 2004).
HBV genome replication is driven solely by the pg RNA, which
serves not only as the messenger for both core and P proteins, but also
as the genome precursor. The 5′ end of this 3.5-kb mRNA, which is
missing in the shorter transcripts, forms a stem–loop structure that
functions as the encapsidation signal. It is believed that one molecule
each of pg RNA and P protein is packaged into the capsid, where the P
protein synthesizes the minus strand DNA from the pg RNA template
by reverse transcription, using a domain of the P protein as the protein
primer. The P protein subsequently degrades pg RNA via its RNase H
domain, and synthesizes plus stranded DNA through the template of
minus strand DNA. The capsid is subsequently released from the cell
by budding and in doing so acquires its envelope and the three
envelope proteins. Virion-associated HBV genome contains full-length
minus strand DNA, and a plus strand DNA of variable lengths (from 50
to 100%). In contrast, both double stranded DNA and DNA: RNA hybrid
(single stranded DNA) can be detected inside intracellular capsids.
This difference in genome maturity suggests the presence of a
“maturation signal” for selective or preferential envelopment of
capsids containing double stranded DNA genome. In this regard,
virion-associated DHBV core protein is hypophosphorylated relative
to the intracellular core particles (Pugh et al., 1989). However,
mutating the three phosphorylation sites of HBV core protein affected
the efﬁciencies of pg RNA encapsidation and genome replication
(Gazina et al., 2000; Lan et al., 1999; Melegari et al., 2005), not
necessarily the stringency of virion secretion. A more recent study in
the DHBV model suggests that alanine substitutions (to mimic
unphosphorylated form) blocked reverse transcription, while aspar-
tate substitutions (to mimic phosphorylated form) blocked plus
strand DNA synthesis (Basagoudanavar et al., 2007). On the other
hand, a naturally occurring I97L mutation in the core protein caused
an “immature secretion phenotype” of predominantly single stranded
DNA (Yuan et al., 1999). We found that the extra 12-amino acid
residues unique to the core protein of genotype G reduced virion
secretion efﬁciency but increased genomematurity of secreted virions
(Li et al., 2007).
Mutations that alter HBV replication capacity may have a
fundamental impact on its biology and pathogenesis. In this regard,
both the pg RNA, the only transcript required for genome replication,
and the pc RNA (the HBeAg messenger) are under the control of the
core promoter. They are products of imprecise transcription initiation,
although distinct sequence elements within the core promoter can
differentially regulate the transcription of pc RNA vs. pg RNA (Yu and
Mertz, 1996). The core promoter can be further divided into the core
upstream regulatory sequence and basal core promoter (Honigwachs
et al., 1989; Yuh et al., 1992), where mutations frequently arise during
the later stage of chronic HBV infection (Kidd-Ljunggren e al., 1997;
McMillan et al., 1996; Okamoto et al., 1994). The hot-spot double
mutation in the core promoter, A1762T/G1764A, was found by site-
directed mutagenesis to moderately increase genome replication and
decrease HBeAg expression in transiently transfected human hepa-
toma cell lines (Buckwold et al., 1996; Li et al., 1999; Scaglioni et al.,
1997). In a previous study, we compared in vitro replication capacity
of genotype A HBV clones isolated from patients at the HBeAg positive
stage of chronic infection (Parekh et al., 2003). Remarkably, clones
harboring wild-type core promoter sequence all had low replication
capacity in transiently transfected Huh7 human hepatoma cell line,
whereas all the high replicating clones harbored core promoter
mutations. Clone 4B with quadruple core promotermutation (T1753C,
A1762T, G1764A, and C1766T) had 10–20 times higher replication
capacity than clone 2A, which has a wild-type core promoter
sequence. Furthermore, introducing the quadruple mutation into
clone 2A was sufﬁcient to markedly boost its replication capacity to a
level comparable to that of clone 4B (Parekh et al., 2003). Tosystemically identify mutations that affect viral RNA transcription,
protein expression, genome replication, and virion secretion we
generated chimeric constructs between the 2A and 4B genomes.
Functional analysis revealed many unexpected features.
Results
The 2A and 4B genomes differ at 46 positions of the 3221-nt
genome (1.4%). They had been cloned to the EcoRI site of pUC18 vector
as tandem dimers (Parekh et al., 2003). Initially, seven chimeric
constructs were generated by fragment exchange using the unique
AvrII (position 177), EcoRV (1039), RsrII (1570), and ApaI (2599)
restriction sites. As shown schematically in Fig. 1A, three of the seven
constructs are 4B based with a shorter restriction fragment derived
from 2A (chi1–chi3), while the other four are 2A based (chi4–chi7).
Availability of both types of constructs permitted us to achieve reliable
results. Virtually all the phenotypes were mapped to the 1-kb RsrII–
ApaI restriction fragment, which covers the core promoter region, the
entire core gene, and the 5′ end of the P gene (Fig. 1B). The
determinants for these phenotypes were further narrowed down
using 9 additional constructs for which the basal core promoter region
(positions 1570–1813), 5′ 2/3rd of the core gene (1814–2330), or the
3′ end of core gene/5′ end of P gene (2331–2599) was selectively
exchanged by overlap extension PCR (Fig. 1A, chi8–chi16).
Sequence variations in the core gene in addition to the core promoter
mutations affect the steady state levels of pc RNA and pg RNA
Fig. 1C shows the result of a representative primer extension assay
of total RNA extracted fromHuh7 cells at day 4 posttransfection. Clone
2A displayed a pc RNA/pg RNA ratio of about 1:1.5, while clone 4B
produced 2–4 times higher levels of the pg RNA but a negligible
amount of pc RNA. The transcriptional difference between the two
genomes could be mapped to the 1-kb RsrII–ApaI restriction fragment
covering nucleotides 1570–2599 (Fig. 1C, compare chi1, chi2 with chi3
in the left panel; compare chi4–chi6 with chi7 in the right panel).
Further study established that the 1570–1813 segment of the 4B
genome, which harbors the T1753C, A1762T, G1764A, and C1766T core
promotermutations, up regulated pg RNA but nearly abolished pc RNA
(chi9 vs. 4B; chi11 vs. 2A). Analysis of site-directed mutants of clone
2A revealed comparable impact of the A1762T/G1764A/C1766T triple
mutation (mu 2a), slightly lower effect of the T1753C/A1762T/
G1764A triplemutation (mu 4), and least effect of the A1762T/G1764A
doublemutation (mu 1) (Fig. 2B).Western blot analysis of core protein
expression revealed a very similar pattern (Fig. 2C). These results
correlate well with the HBeAg expression and genome replication
phenotypes of the mutants (Parekh et al., 2003), suggesting that these
core promoter mutations suppress HBeAg expression and augment
genome replication at the transcriptional level.
Surprisingly, three chimeric constructs with core promoter muta-
tions producedmore pg RNA than clone 4B (Fig. 1C, chi8, chi11, chi15),
and they share a 2A-derived 5′ core gene (1814–2330 fragment)
(Fig. 1A). The impact of the 1814–2330 fragment can also be observed
among constructs lacking core promoter mutations, as evidenced by
higher pc RNA and pg RNA levels produced by chi3 than chi9 and chi10
among 4B-based constructs (Fig. 1C, left panel), as well as lower RNA
levels produced by chi12 and chi13 relative to 2A itself (right panel).
Both core promoter and core gene mutations regulate core protein
expression
We used two antibodies to detect core protein expression. A
polyclonal rabbit antibody (Dako) efﬁciently detects the wild-type
core protein, but it is less reactivewith the core protein of clone 4B due
to an E77Q mutation (Kim K et al., unpublished). Binding of this
antibody to core protein of 4B origin is subject to the washing
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shaking), which explains the higher intensity of the Q77 variant in
the left panel of Fig. 1E over the right panel or Fig. 2C. This antibody isuseful in comparing core protein expression levels among constructs
with the same sequence at residue 77. Comparison of the expression
levels between the E77 and Q77 variants requires a monoclonal
Fig. 2. Comparison of pg RNA, pc RNA transcription and core protein expression among
core promotermutants. (A) Sequence at positions 1753,1762,1764, and 1766 of the core
promoter, with the mutations shown in boldface. Chi11 was called Ex2 in the previous
study (Parekh et al., 2003). (B) Primer extension assay of pg RNA and pc RNA. (C)
Western blot analysis of core protein expression. Probing the same blot with GAPDH
antibody revealed similar amounts of protein loading (data not shown).
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different epitope (residues 135–141: PNAPILS) not mutated in either
clone 2A or 4B (Skrivelis et al., 1993). This antibody revealed much
higher core protein expression by clone 4B than clone 2A (Fig. 1D). As
expected, the quadruple core promoter mutation covered by the
1570–1813 fragment markedly enhanced core protein expression,
whethermeasured by the polyclonal or monoclonal antibody (Figs.1D
and E, compare 4B with chi9, and 2A with chi11). Based on results
obtained with the Abcam antibody, the 5′ end of the 4B core gene (the
1814–2330 fragment) was associated with higher core protein level
than the counterpart in clone 2A, whereas its 3′ end (the 2331–2599
fragment) was correlated with lower core protein level. This is true for
core promoter mutants (Fig. 1D, right panel, chi14 vs. chi15 vs. chi11),
as well as constructs with wild-type core promoter sequence (Fig. 1D,
left panel, chi10 vs. chi9 vs. 2A; right panel, chi13 vs. chi12 vs. 2A).
However, when the core protein was expressed from the 0.6-kb core
gene inserted behind the CMV promoter, no apparent difference in
core protein level was observed between clones 2A, 4B, and 6.2, which
contains awild-type core gene (Fig. 3C). Thus, the mutations probably
work in cis to control core protein expression in the context of pg RNA,
rather than affecting core protein stability.
Accelerated mobility of 4B-derived core protein than that of 2A origin
4B-derived core protein migrated at a faster rate than that of 2A
origin (this requires running the core protein near the end of the 12%
separating gel of about 11 cm). This is most conspicuouswith the Dako
polyclonal antibody, which could easily detect 2A-derived coreFig. 1. Chimeric constructs between the 2A and 4B genomes and comparison of RNA transcr
representation of the chimeric constructs. 2A- and 4B-derived sequences are shown as open
genomes. Shown are sequence changes at the nucleotide level, in the basic core promoter (B
above and below each line, respectively. (C) Primer extension assay of pc RNA and pg RNA fro
from day 5 cell lysate using mouse monoclonal antibody 14E11 from Abcam (D) or rabbit po
antibodies. Position of the core protein is indicated. Reprobing the blots with antibody agains
DNA replication at day 5 posttransfection. The 3.2-kb, 1.7-kb, and 1.5-kb size markers are indi
blot analysis of virion-associated DNA from culture supernatant collected at day 5 posttra
polyclonal antibody.protein (Fig. 1E). Considering that neither 2A nor 4B has wild-type
core protein sequence (Fig. 1B), we further compared their migration
patterns with a reference core protein of clone 6.2 containing wild-
type sequence. The 2A core protein showed slightly reduced mobility
relative to that of 6.2, whereas the 4B core protein had an increased
mobility relative to 6.2 (Fig. 3F). Whether the size difference is caused
by mutations that create or destroy a phosphorylation site, or a direct
consequence of amino acid changes, remains to be determined.
Both core promoter and core gene mutations alter genome replication
capacity
The 1-kb RsrII–ApaI fragment was implicated as the major
determinant for differential replication capacities: inserting the 2A
sequence into the 4B background nearly abolished genome replication
(Fig. 1F, left panel, compare 4B with chi3), whereas the reverse
exchange greatly enhanced replication (right panel, 2A vs. chi7).
Further mapping experiments revealed that the core promoter
mutations alone were sufﬁcient to maintain the high replication
capacity of clone 4B (left panel, chi8 vs. 4B) and to confer enhanced
replication to clone 2A (right panel, chi11 vs. 2A). However, evenwith
wild-type core promoter sequence chi9 and chi10 with 4B background
continued to display much higher replication capacity than clone 2A
(left panel). Similarly, chi12 and chi13 showed higher replication
capacity than clone2A, although to amuch smaller extent (right panel).
Thus, either the 1814–2330 fragment of clone 4B enhances genome
replication, or the cognate fragment of clone 2A impairs genome
replication. Thesemutationsmost likelywork in cis, because the 2Aand
4B core proteins supported genome replication to similar extentswhen
co-transfected with the 4B core−mutant (Figs. 3A and D).
The 1814–2599 fragment controls the coupling between genome
maturation and virion secretion
Considering that Huh7 cells secrete both virions and naked core
particles into culture supernatant, we used a horse polyclonal anti-HB
antibody to selectively immunoprecipitate virions. This antibody
failed to precipitate any HBV DNA from culture supernatant of cells
transfected with an HBV mutant defective in envelope protein
expression (data not shown). Virion secretion can be monitored
easily for constructs with high replication capacities. Presence of 4B
core gene sequence (1814–2599 fragment) correlatedwithmuchhigher
proportion of double stranded DNA inside virions (Fig. 1G, chi1, chi2,
chi7, chi12) than the core gene of 2A origin (chi8; chi11). Simultaneous
detection of virions and naked core particles following their separation
through CsCl gradient revealed that genome maturity associated with
clone 4B and chi7 was restricted to virions: their naked core particles
contained predominantly single stranded DNA similar to naked core
particles released by chi8 and chi11 (Fig. 4). For chi8 and chi11, single
stranded DNA was found inside both virions and naked core particles,
suggesting a loss of quality control during virion formation. Treatment
of DNA sampleswith heat prior to electrophoresis, which denatures the
double stranded DNA into single stranded form but has no affect on the
single stranded DNA, conﬁrmed immature secretion phenotype of chi8
and chi11 (Fig. 5). Constructs with a mosaic core gene secreted virus
particleswith an intermediate degree of genomematurity (Fig.1G, rightiption, core protein expression, genome replication, and virion secretion. (A) Schematic
and ﬁlled boxes, respectively. (B) Mutations within the RsrII–ApaI fragment of the two
CP), and in the core and P (pol) proteins. Changes in the 2A and 4B genomes are listed
m cells harvested at day 4 posttransfection. (D, E) Western blot analysis of core protein
lyclonal antibody from Dako (E). The same blots were sequentially probed with the two
t GAPDH revealed similar protein loading (data not shown). (F) Southern blot analysis of
cated. RC: relaxed circular; DL: double stranded linear; SS: single stranded. (G) Southern
nsfection. Virions were immunoprecipitated from culture supernatant by an anti-HBs
Fig. 4. Comparison of genome maturity of virions and naked core particles among
constructs with 2A- and 4B-derived core gene. Virions and naked core particles were
separated by ultracentrifugation through CsCl gradient, and about 11 fractions were
taken from the top. Fractions 3–10were analyzed by Southern blot. RC: relaxed circular;
DL: double stranded linear; SS: single stranded. The density of each fraction is provided
at the bottom.
Fig. 3. Reconstitution of HBV genome replication and virion secretion between 4B core− dimer and a CMV promoter-driven core protein construct of 2A, 4B, or 6.2 origin. Huh7 cells
were co-transfected with 1 μg of 4B core− dimer and 0.2–1 μg of CMV-core construct (panels A–C), or 0.5 μg of 4B core− dimer and 0.3–1.5 μg of CMV-core construct (panels D and E).
As a positive control, cells were transfected with 1 μg or 0.5 μg of 4B dimer. (A, D) Southern blot analysis of genome replication at day 5 posttransfection. DL: double stranded linear
DNA; SS: single stranded DNA. (B, E) Southern blot analysis of virion secretion at day 5 posttransfection. (C) IP-Western blot analysis of core protein expression. Core protein was
immunoprecipitated from cell lysate using the Dako antibody, and detected in Western blot sequentially with the Dako and Abcam antibodies. Positions of antibodies used in IP (Ig)
and core protein are indicated. (F) Comparison of mobility of core protein expressed from EcoRI dimers of 2A, 4B, and 6.2 genomes.
368 A. Tsai et al. / Virology 387 (2009) 364–372panel, chi14 and chi15), suggesting that both the 5′ and 3′ ends of the
core gene affect the maturity of virion-associated DNA.
The core gene rather than the P gene determines the secretion phenotype
The 3′ end of the core gene overlaps with the 5′ end of the P gene,
which is mutated in clone 4B (D16V, T18A) but not 2A (Fig. 1B). To
verify whether mutations in the core or P protein determine the
stringency of virion secretion, we generated core− and ɛ−/p−
mutants of both 2A and 4B genomes. The core− mutants will express
P protein and their pg RNA is capable of encapsidation and conversion
to DNA. In contrast, the ɛ−/p− mutants serve as the source of coreFig. 5. Veriﬁcation of virion-associated double and single stranded DNA via heat
treatment. Virions were immunoprecipitated from culture supernatant by an anti-HBs
antibody, and DNA extracted was divided into two equal parts. One part was heated at
95 °C for 5 min and cooled down on ice. DNAwas separated in 1.5% agarose gel followed
by Southern blot analysis. DS: double stranded; SS: single stranded; RC: relaxed
circular; DL: double stranded linear.
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competent when transfected alone (data not shown). Co-transfection
of 1.5 μg of 4B ɛ−/p− mutant with 0.5 μg of its core− mutant
reconstituted much higher genome replication than co-transfection at
a 0.5 μg/1.5 μg ratio (Fig. 6A, lane 12 vs. lane 4). In contrast, co-
transfection of 4B ɛ−/p− mutant with 2A core− mutant at 0.5 μg/
1.5 μg ratio reconstituted slightly more genome replication than co-
transfection at a 1.5 μg/0.5 μg ratio (lane 6 vs. lane 14). Co-transfection
of 2A ɛ−/p− mutant with 4B core− mutant did not lead to efﬁcient
genome replication at any ratio. Importantly, use of 2A ɛ−/p−mutant as
the source of core protein invariably led to the secretion of virions
containing single stranded DNA, whether in conjunction with 2A or 4B
core−mutant (Fig. 6B, odd numbered lanes). In contrast, the 4B ɛ−/p−
mutant always conferred secretion of predominantly double stranded
DNA, with a very small proportion of single stranded DNA (even
numbered lanes).
The 2A- and 4B-derived core proteins respectively reduce and enhance
maturity of virion-associated genomes
Avariable in the trans-complementation experiments between the
2A and 4B genomes is the efﬁciency of genome replication, as most
odd numbered lanes in Fig. 6 had lower replication capacity than even
numbered lanes. To further validate the role of the core protein in the
virion secretion phenotype, we inserted the 0.6-kb core gene of clones
2A, 4B, and 6.2 (wild-type) into an expression vector driven by the
CMV promoter, and performed co-transfection experiments with the
4B core− mutant. Efﬁcient reconstitution of genome replication
required a high dose of the core protein construct (compare Fig. 3A
with Fig. 3D), but there was little difference between the three core
protein constructs. At all the doses tested, the 4B core protein wasFig. 6. Trans-complementation assay between ɛ−/p− and core− mutants. The ɛ−/p−
mutant can express core proteinwhile the core−mutant expresses the P protein and its
pg RNA can serve as the pregenome for encapsidation and conversion toDNA. Huh7 cells
were co-transfectedwith ɛ−/p−mutant and core−mutant at 0.5 μg/1.5 μg,1 μg/1 μg, or
1.5 μg/0.5 μg ratio, and harvested 5 days later. As positive controls, cells were transfected
with 1 μg of clone 2A (lane 15) or 4B (lane 16) together with 1 μg of pcDNA3.1 vector.
Lane 17:mock transfected cells. (A) Southern blot analysis of DNA replication inside core
particles. (B) Southern blot analysis of virions secreted to culture supernatant. (C)
Western blot analysis of core protein in cell lysate using the polyclonal antibody from
Dako (upper panel) and reprobing of the same blotwith GAPDH antibody (lower panel).invariably associated with a higher degree of genome maturity of
secreted virions than the wild-type core protein of 6.2, whereas the 2A
core protein was associated with a lower degree of genome maturity
than 6.2 (Figs. 3B and E). This ﬁnding, together with the results of the
mapping experiments, establishes that amino acid substitutions at the
N-terminus of the 2Acoreprotein (A36TorG63V) reduce the stringency
of virion secretion,whereas aminoacid changes at theC-terminus of the
4B core protein (T147A, R151C, D153G, or Q179K) enhance genome
maturity of secreted virions.
Discussion
In the previous study we observed marked differences in
replication capacity among naturally occurring HBV isolates belonging
to genotype A, and found a correlation between the high replication
capacity and presence of core promoter mutations (Parekh et al.,
2003). The most common core promoter mutations, A1762T/G1764A,
had been found by other investigators to moderately increase genome
replication (Buckwold et al., 1996; Moriyama et al., 1996; Scaglioni
et al., 1997). However, we observed much greater variations in
replication capacity among the natural HBV isolates, with the highest
replicating clones harboring additional point mutations in the core
promoter. Thus, clone 4B contains a combination of T1753C, A1762T,
G1764A, and C1766T mutations in the core promoter and replicated
about 10–20 times more efﬁciently than clone 2A with a wild-type
core promoter sequence. Simply introducing the quadruple mutation
or just the 1762/1764/1766 triple mutation into clone 2A conferred
about a 10-fold increase in genome replication, while the 1753/1762/
1764 triple mutation and the 1762/1764 double mutation increased
genome replication by about 4-fold and 2-fold, respectively. In
addition, the 1762/1764, 1753/1762/1764, 1762/1764/1766, and
1753/1762/1764/1766 mutations reduced HBeAg expression by 20–
80% (Parekh et al., 2003). In the present study, we found that the
quadruple and 1762/1764/1766 triple mutation caused the greatest
increase in pg RNA transcription and inhibition of pc RNA transcription,
whereas the 1762/1764 double mutation was least effective (Fig. 2B).
The expression of core protein followed a similar trend as the pg RNA
(Fig. 2C). Therefore, the core promoter mutations studied here increase
genome replication by up regulation of pg RNA transcription; they
suppress HBeAg expression through reduced pc RNA transcription.
A core promoter mutant implicated in an outbreak of fulminant
hepatitis also exhibited a much higher replication capacity in cell
culture than a wild-type clone of the same genotype (Hasegawa et al.,
1994; Liang et al., 1991). The high replication capacity was mapped to
nucleotides 1574–1986, where 7 core promotermutations are present:
G1751T, T1753A, G1757A, A1762T, G1764A, C1766T, and T1768A.
Remarkably, introduction of the C1766T/T1768A double mutation
alone into a wild-type background reproduced a 15-fold increase in
replication capacity (Baumert et al., 1996). Elegant studies were
followed to elucidate the mechanism involved. The double mutation
incurred merely a 2-fold increase in total pg RNA level and P protein
expression (based on a reporter assay), but increased core protein
expression by 15 fold and greatly increased pg RNA encapsidation
(Baumert et al., 1998). High replication capacity could be reconsti-
tuted by co-transfecting the ɛ− mutant of the core promoter mutant
with the core−/p−mutant of thewild-type virus, or its ɛ−/p−mutant
with the core− mutant of the wild-type virus. In contrast, co-
transfection of its core−/p− mutant with the ɛ− mutant of the wild-
type virus, or its ɛ−/core−mutantwith the p−mutant of thewild-type
virus, did not yield high replication capacity. Our trans-complementa-
tion experiments between the 2A and 4B genomes gave rise to very
similar results when the ɛ−/p− mutant was co-transfected with the
core−mutant at a ratio of 1:1 (Fig. 6, lanes 9 and 10). However, trans-
complementation between a core promoter mutant and a wild-type
virus at a 1:1 ratio would inevitably lead to the assignment of the high
replication phenotype to the core gene, even though expression of the
370 A. Tsai et al. / Virology 387 (2009) 364–372P protein, as well as the pg RNA available for encapsidation, are also
increased.We found that the optimal ratio between the ɛ−/p−mutant
and core−mutant of the same genome for DNA replicationwas 3:1, not
1:1 or 1:3, as exempliﬁed by clone 4B (Fig. 6A, lanes 12, 8, 4). The
requirement for less core− mutant for genome replication could be
explained by the fact that only about 1/10th of the pg RNA is
encapsidated, and that P protein expression is enhanced by 2–3 fold in
the absence of core gene translation, at least in theDHBVmodel (Sen et
al., 2004). Therefore, elucidating themechanism of the high replication
capacity of a core promoter mutant by trans-complementation assay
would require experiments under a range of ratios between the
complementing constructs such that each component is tested as a
limiting factor for replication. The fact that co-transfecting 4B ɛ−/p−
mutant with 2A core− mutant at 1:3 ratio was as efﬁcient in
reconstituting genome replication as co-transfection at 3:1 ratio
(Fig. 6, lane 6 vs. lane 14) is consistent with clone 4B's higher pg RNA
transcription rate.
Similar to the fulminant hepatitis strain (Baumert et al., 1998;
Baumert et al., 1996), we found a small (2–4 fold) difference in the
levels of total pg RNA between clones 2A and 4B despite a much
greater difference in their replication capacities (Figs. 1C and E).
Simply introducing the core promoter mutations into clone 2A led to
higher pg RNA level than achievable by clone 4B (chi11, Fig. 1C).
Analysis of all the chimeric constructs suggests that the 5′ end of the
4B core gene (nucleotides 1814–2330), which contains 4 nucleotide
changes (Fig. 1B), suppresses pg RNA production or its accumulation.
Alternatively, the 5′ end of the 2A core gene, which contains 2
nucleotide changes, increases pg RNA production or prolongs its half
life. Interestingly, the 2A sequence at the 5′ end of the core gene was
associated with reduced core protein level, as well as reduced genome
replication, relative to 4B sequence. Thus, discordance between the pg
RNA and replicating DNA levels were sometimes observed: achi12 and
chi13 had higher replication capacity than clone 2A despite lower
levels of pg RNA and pg RNA. Similarly, chi7 and chi9 had similar level
of pg RNA as 2A, but much higher replication capacity (Figs. 1C and F).
We hypothesize that the rate of core particle assembly is greatly
enhanced with increasing core protein concentration. The core
promoter mutations increase core protein (as well as P protein)
expression leading to more efﬁcient pg RNA encapsidation and
conversion to DNA, thus reducing the pool of free pg RNA. Such an
encapsidation-mediated reduction in free pg RNA is disrupted by
mutations in the 2A genome, which reduce core protein expression to
a concentration insufﬁcient for core particle assembly and pg RNA
conversion. Our hypothesis can be tested by comparing transcript
levels between clone 4B (or 2A) and its ɛ−/p− mutant or core−
mutant. Analternative hypothesis is suggest bya recent elegant study in
the DHBV model, where the P protein was found to inhibit reporter
protein expression at the transcriptional level (Cao and Tavis, 2006).
Further analysis demonstrated ability of the P protein to feed back and
reduce its own transcript, the pg RNA aswell (Cao and Tavis, 2006). This
hypothesis can explain why the level of pc RNA, which is not
encapsidated, is affected bymutations in the 5′ end of core gene aswell.
The virion secretion phenotype of clone 2A has not been well
characterizeddue to its low replication capacity. Simplyaugmenting the
replication of clone 2A by core promoter mutations revealed envelop-
ment and secretion of core particles harboringprimarily single stranded
DNA (Fig. 1G, chi11), in sharp contrast to the double stranded DNA
secreted by clone 4B. Constructs with hybrid core gene showed
intermediate phenotypes (chi14 and chi15, Fig. 1G), suggesting a
contribution of both the 5′ and 3′ ends of the core gene. The two types of
trans-complementation assays shown in Figs. 3 and 6 clearly indicate
that amino acid changes in the core protein are responsible for altered
genome maturity. Moreover, together with the results of chimeric
constructs they suggest that mutations present at the N-terminus of 2A
core protein (A36T or G63V) reduce the stringency of virion secretion,
whereas mutations present at the C-terminus of the 4B core protein(T147A, R151C, D153G, or Q179K) enhance genomematurity of secreted
virions. In this regard, other naturally occurring sequence variations in
the core gene have been found to modulate virion secretion. An F97L
mutation causes the immature secretion phenotype, which could be
overcome by a P130Tmutation (Yuan et al.,1999; Yuan and Shih, 2000).
In contrast, a P5Tmutation impairs virion secretionwhen present alone
and restores wild-type secretion phenotype when combined with the
I97Lmutation (Chua et al., 2003). The 12-aa insertion unique to the core
protein of genotype G reduces the efﬁciency of virion secretion but
enhances genome maturity, as does the myristoylation signal in the L
envelope protein (Gripon et al., 1995; Li et al., 2007).
We can envision two mechanisms to alter the genome maturity of
secreted virions. First, a mutation directly facilitates or impedes plus
strand DNA synthesis. Such amutation can occur in the core gene or the
P gene and is expected to alter the genome maturity of both replicative
DNA inside cells and virion-associated DNA. Mutations in the
phosphorylation sites of the core protein may have such an effect
(Basagoudanavar et al., 2007). Second, a mutation in the core gene or
envelope gene reset the time point of capsid envelopment, thus altering
the genomematurity of virions but not necessarily intracellular capsids.
The myristoylation signal in the L protein and the 12-aa insertion in the
core protein probably ensure delayed envelopment of core particles.
Since the mature genome represents a small fraction of intracellular
capsids, possibly due to reduced capsid stability during genome
maturation (Kock et al., 2003), a delay in the envelopment often results
in reduced efﬁciency of virion formation. In the present study, the defect
in minus strand DNA synthesis was seen mostly with secreted virus
particles rather than with intracellular naked core particles (chi 7 vs.
chi11, compare Fig.1Fwith Fig.1G), but at lowconcentration the 4B core
protein was associated with higher genome maturity even for
intracellular core particles (Figs. 3A and D, 0.2 μg and 0.3 μg of CMV-
core constructs, respectively). Also, the virion secretion efﬁciency was
not reduced by the 4B core gene or increased by the 2A sequence. These
features are more consistent with the ﬁrst mechanism.
Most studies aimed at characterizing the functional consequences
of naturally occurring mutations in the HBV genome employ the
approach of site-directed mutagenesis of a wild-type clone. While this
approach is straightforward and the results obtained are easily
interpretable, they fail to identify complex interactions among
coevolving mutations. An alternative approach is to generate and
characterize chimeric constructs between two HBV isolates, which is
necessary when an HBV isolate possesses an unusual phenotype (such
as high replication or failure of virion secretion) but the underlying
mutation cannot be deduced from the sequence information. This
approach is extremely time consuming and data interpretation can be
complicated if both genomes contain mutations. Nevertheless, we
have successfully used this approach to identify an G119E mutation in
the envelope gene as responsible for impaired virion secretion of an
HBV isolate, and also revealed ability of an M133T mutation in the
envelope gene of clone 4B to overcome an I110M mutation, which
would otherwise block virion secretion (Khan et al., 2004). In the
present study, characterization of 16 chimeric constructs between the
2A and 4B genomes revealed pleiotropic effects of sequence variations
in the core gene on RNA transcription, core protein expression,
genome replication, and virion secretion. Further investigation will
attempt to connect these phenotypic changes and identify novel
regulatory mechanisms in the HBV life cycle.
Methods
Chimeric constructs, site-directed mutants, and expression constructs
Chimeric constructs between 2A and 4B genomes were generated
by restriction fragment exchange, using the unique AvrII, EcoRV, RsrII,
and ApaI sites present on the HBV genome (Fig.1A). Overlap extension
PCR was used to replace a fraction of the sequence within the RsrII–
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into a monomer, the chimeric HBV genome was released from the
pUC18 vector by EcoRI digestion, and ligated with EcoRI-cut, dephos-
phorylated pUC18 DNA at high insert: vector ratio. Clones harboring
tandem dimers were identiﬁed by colony hybridization with an
oligonucleotide probe and conﬁrmed by restriction enzyme digestion
as described previously (Parekh et al., 2003). Site-directed mutants
were created by overlap extension PCR followed by restriction fragment
exchange. The core− mutants contain a C2044A change that converts
codon 48 from TGC toTGA. The ɛ−/p−mutants harbor G1879T/T1880A
double mutation that abolishes pg RNA encapsidation (Bang et al.,
2005) as well as a C2589T nonsense mutation of the 95th codon of P
gene. The CMVpromoter-driven core protein constructswere generated
by inserting a 0.6-kb sequence encompassing the core gene into the
XhoI–EcoRI sites of the pcDNA3.1 zeo(−) vector (Li et al., 2007).
Transient transfection and analysis of HBV genome replication and
virion secretion
Detailed experimental procedures have been described elsewhere
(Bang et al., 2005; Guarnieri et al., 2006; Khan et al., 2004; Li et al.,
2007; Parekh et al., 2003) except for some minor modiﬁcations.
Brieﬂy, Huh7 cells seeded in 6-well plates at 50–80% conﬂuency were
transfected with 2 μg of HBV dimer DNA together with 5 ng of cDNA
encoding secreted alkaline phosphatase (SEAP) using the LT1 reagent
(Mirus). Cells and culture supernatant were harvested 5 days
posttransfection. The SEAP activity was measured from an aliquot of
culture supernatant using a commercial assay (Clontech). Virus
particles were immunoprecipitated from 1.5ml of culture supernatant
by a 1.5 μl of the anti-HBs antibody (horse polyclonal anti-Ad/Ay,
Abcam) conjugated to protein G beads. The immunoprecipitate was
resuspended in 50 μl of 10 mM Tris, pH 7.4, 6 mM MgCl2, and 8 mM
CaCl2 solution, and treated with 4 U of DNase I and 6 U of mung bean
nuclease at 37 °C for 20 min. This was followed by addition of 135 μl of
proteinase K buffer (25 mM Tris, pH 7.5, 100 mM NaCl, 10 mM EDTA,
0.5% SDS) and proteinase K to 0.5 mg/ml. After incubation at 37 °C for
about 2 h, DNA was extracted with phenol and precipitated with
ethanol in the presence of glycogen. DNA was separated in 1.2%
agarose gel for about 3–4 h at about 7–8 V/cm gel to prevent
overheating. After transfer, the blots were hybridized with a 32P dCTP
labeled HBV DNA probe prepared by random priming (Megaprime kit,
Amersham). The 3-kb template DNA for probe preparation was
generated from clone 2A by PCR. The blots were washed at 65 °C in
2XSSC/0.1% SDS solution. To verify virion-associated HBV DNA as
double or single stranded, each DNA sample was divided into two
equal parts. One part was heated at 95 °C for 5 min followed by
quenching on ice. DNA was separated in 1.5% agarose gel.
Cellswere lyzedon ice for 10minwith 10mMHepes pH7.5/100mM
NaCl/1 mM EDTA solution supplemented with 1% NP40 to obtain
cytoplasmic extract. Core particles were precipitated from half of the
cell lysate by PEG, treated sequentially with nucleases and proteinase K,
followed by DNA extraction for Southern blot analysis. The other half
was used for Western blot analysis of core protein expression.
Separation of virions from naked core particles by ultracentrifugation
through CsCl gradient
As described previously (Parekh et al., 2003), precleared culture
supernatant (9 ml) was layered on top of 1 ml each of the 20% and 10%
sucrose in TEN buffer, and centrifuged in a Sorvall TH-641 rotor at
39,000 rpm for 20 h. The pellet was dissolved in 4.8 ml of TEN buffer,
supplemented with 1.6 g of CsCl, and centrifuged in a Sorvall AH-650
rotor at 46,000 rpm for 66 h. Fractions of 400 μl each were collected
from top, weighed, and dialyzed against TEN buffer. Each sample was
supplemented with 8 mM CaCl2 and 6 mM MgCl2 and digested with
4 U of DNase I and 6 U of mung bean nuclease at 37 °C for 20 min. Tris(pH7.5), EDTA (pH8.0), SDS, and proteinase K were added to ﬁnal
concentrations of 25 mM, 10 mM, and 0.5%, 0.5 mg/ml, respectively,
followed by digestion at 37 °C for 2 h. After phenol extraction and
isopropanol precipitation in the presence of glycogen, HBV DNA was
analyzed by Southern blot.
Core protein detection
Half of the cell lysate was used for Western blot analysis. Proteins
were separatedovernight in SDS-12%polyacrylamidegel until the 21-kd
core proteinwas about 1 cm to the bottom of the gel as judged from the
prestained molecular size markers. After transfer, the blot was
incubated at room temperature for 30 min with 3% bovine serum
albumin (BSA) dissolved in TBST solution (50 mM Tris, pH 7.5, 125 mM
NaCl, 0.1% Tween 20) followed by incubation at 4 °C for 2–3 nightswith
themonoclonal antibodyagainst coreprotein (14E11, Abcam) at1: 2000
dilution in 3% BSA–TBST. The blot was washed at room temperature for
40 min (10 min×4 times) with TBST solution, and further incubated at
room temperature for 1 hwith a 1: 40,000–60,000 dilution (in 3% BSA–
TBST) of rabbit anti-mouse antibody conjugated with horseradish
peroxidase (HRP). Following another wash of 40 min, signals were
revealed by enhanced chemiluminescence (ECL). The antibodies were
removed by shaking the blot at 37 °C for 20 min in the stripping buffer
(Pierce), followed by extensive rinse with water, and wash with TBST
solution for 40 min. The blot was blocked again with 3% BSA-TBST
solution, and incubated at 4 °C overnight with the polyclonal rabbit
antibody against core protein (Dako) at 1:2000 dilution. The
remaining steps are similar to that for the monoclonal antibody,
except that the HRP-conjugated goat anti-rabbit antibody (Upstate)
was used at 1:100,000 dilution. The blot was stripped again, and used
for the detection of glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) using a mouse monoclonal antibody (Chemicon) at 1:
10,000 dilution, and anti-mouse antibody at 1: 40,000 dilution.
In some experiments, core protein was detected by immuno-
precipitation followed by Western blot analysis. In this case, the cell
lysatewas diluted with PBS to a ﬁnal volume of 400 μl, and incubated at
4 °C overnight with a 1:1000 dilution of the Dako antibody. After
addition of 10 μl of protein G-Agarose beads and a further incubation of
4 h, the immunoprecipitate was collected by low speed centrifugation,
washed once with PBS, and resuspended in protein loading buffer. The
subsequent Western blot analysis was the same as described above.
Primer extension assay for pc RNA and pg RNA
This was performed essentially as described before (Bang et al.,
2005) using a commercial kit (Primer extension system-AMV reverse
transcriptase, Promega). Huh7 cellswere lyzed at day 4posttransfection
using Trizol (Gibco/BRL), and total cellular RNA was extracted with
chloroform, and precipitated with isopropanol. RNA concentration was
determined by spectrometer and conﬁrmed by running an aliquot in
agarose gel. Ten microgram of RNA was annealed at 58 °C for 20 min
with an antisense oligonucleotide 5′-GAGACTCTAAGGCTTCTCGATAC-3′
(positions 2033–2010) that had been end labeled with γ-32P ATP using
T4 polynucleotide kinase. The annealed oligonucleotide was extended
by AMV reverse transcriptase at 42 °C for 30 min. The product was
heated at 90 °C for 10 min and separated in 5% polyacrylamide gel
containing urea (National Diagnostics) using 1× TBE buffer. The HaeIII
digestedϕx-174DNAwas end labeledwithγ-32PATP and run inparallel
to serve as molecular size markers. The gel was dried and radioactive
signals were detected by autoradiography.
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